BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Catalent Pharma Solutions Release: New Interactive Web Tool Helps Innovators Match Formulations to Drug Delivery Technologies


11/8/2013 9:31:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Somerset, NJ – November 8, 2013 — Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced that it is to launch its new ‘FormProRx’ web tool on November 11th, during the forthcoming 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. This innovative web-based scientific resource has been exclusively developed by leading Catalent experts to assist drug development teams seeking to determine the optimal finished dose suited to their product based on product requirements, target indications and molecule properties. FormProRx allows users to assess multiple oral drug delivery technologies in order to establish which may be the most appropriate for their molecule.

Formulators and process development scientists can easily utilize the tool by inputting chemical characteristics and product specifications to generate recommendations based on Catalent’s 75+ years of experience in bioavailability enhancement and applied drug delivery. Users can gain access to a customized report for their Active Pharmaceutical Ingredient (API) Characteristics and product requirements across 24 dimensions under the categories ‘Solubility & Permeability,’ ‘Physiochemical Properties’, ‘Potent Handling’ and ‘API Processing.’ On completing the profile, the user then immediately receives a detailed report on which drug delivery technologies could be appropriate for further investigation. Whether for a new drug or a line extension, insights from FormProRx may suggest new approaches that benefit pharmacokinetics, patient adherence or the formulation’s therapeutic profile.

"It is ever more challenging to deliver drugs effectively in a form that is convenient for patients and minimizes side effects. Formulators can drive better outcomes through familiarity with the many drug delivery technologies available," commented Dr. Kurt Nielsen, Chief Technology Officer and Senior Vice President of Innovation and Growth at Catalent. “By introducing a tool that suggests drug delivery technologies based on the specific characteristics of the molecule, and yet is fast and easy-to-use, Catalent aims to help innovators improve their treatments and advance them faster. It is built on the knowledge of many scientists with broad experience developing hundreds of molecules and provides an excellent aid to development teams.”

A trained team of experts will be available to discuss FormProRx and offer live demonstrations at AAPS, Catalent booth (1612). For further information or to schedule a demonstration at the meeting, please contact Richard Kerns at NEPR, richard@nepr.eu.

About Catalent

Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES